Honda Motor Co affiliates have agreed to pay $85 million to settle an investigation by most US states into its use of defective Takata airbag inflators in its vehicles.
Honda of America and American Honda Motor Co also agreed to upgrade their product safety procedures related to frontal airbags, including the reduction of rupture risks in the inflators.
The Honda affiliates also agreed to the consent order without admitting wrongdoing, to avoid the cost of further litigation.
Honda had reached civil settlements with 46 US states, Washington, DC, and three US territories over the matter.
The probes are connected with the ongoing recalls of the now over 40 million Honda vehicles equipped with 60 million defective Takata airbags that were sold over the past 20 years.
The airbags have been recalled because the inflators can explode when deployed.
At least 25 deaths and nearly 300 injuries globally have been linked to faulty Takata inflators.
The recalls cover about 100 million inflators among 19 major automakers, including Honda.
In January, Honda announced it would recall an additional 2.7 million older US vehicles in North America covering the 1996 through 2003 model years.
Since 2008, Honda has recalled nearly 13 million U.S. vehicles equipped with Takata inflators and has replaced more than 16 million inflators.
A multistate group of attorneys general had been investigating Honda’s use of Takata airbags since December 2015, according to the consent order.


Google to Move All Pixel Production Out of China by 2027
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Standard Chartered Expands Hedge Fund Access for Wealth Clients
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
REPAY Stock Rises After Visa Platform Connect Collaboration
OpenAI Tightens AI Safety Monitoring After Security Incidents
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate 



